ロード中...

Histone deacetylase inhibition promotes intratumoral CD8(+) T-cell responses, sensitizing murine breast tumors to anti-PD1

Histone deacetylase (HDAC) inhibitors impair tumor cell proliferation and alter gene expression. However, the impact of these changes on anti-tumor immunity is poorly understood. Here, we showed that the class I HDAC inhibitor, entinostat (ENT), promoted the expression of immune-modulatory molecules...

詳細記述

保存先:
書誌詳細
出版年:Cancer Immunol Immunother
主要な著者: McCaw, Tyler R., Li, Mei, Starenki, Dmytro, Liu, Mingyong, Cooper, Sara J., Arend, Rebecca C., Forero, Andres, Buchsbaum, Donald J., Randall, Troy D.
フォーマット: Artigo
言語:Inglês
出版事項: Springer Berlin Heidelberg 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6879872/
https://ncbi.nlm.nih.gov/pubmed/31720815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-019-02430-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!